Skip navigation



Cabume -

Cambridge Business Magazine

Cambridge Epigenetix Licenses Fundamental DNA Methylation IP from Boston Children’s Hospital

Exclusive licence enables the development and commercialisation of 5hmC technologies for epigenetic biomarker discovery More »
28 April 2017

Heptares Collaboration with AstraZeneca yields New Insights to Advance Drug Discovery in Pain, Cancer and Inflammation

Novel mechanisms of action highlighted from resolved structures of PAR2 bound to antagonist molecules – research published in Nature More »
27 April 2017

Bactevo Unveils ‘TIME’ a Novel, Game-Changing Medicines Discovery Platform

Achieves 100 Million Disease-Relevant Assays per Hour Incorporates Ground-Breaking Synthetic Chemistry Platform Management Team and SAB Expanded to Accelerate Next Phase of Growth More »
25 April 2017

Organoid Banking: Cryopreservation & Thawing of Organoids

AMSBIO reports on an independent study** that evaluated the use of CELLBANKER® and STEM CELLBANKER® reagents for cryopreservation and thawing of organoids. More »
25 April 2017

ReViral Announces Good Safety and Pharmacokinetics From Phase 1 Programme for RSV Antiviral RV521 in Healthy Volunteers

ReViral Announces Good Safety and Pharmacokinetics From Phase 1 Programme for RSV Antiviral RV521 in Healthy Volunteers. Phase 2a RSV Challenge Study Planned for Q3 2017. More »
24 April 2017

'Ring the Changes' - Global Regulatory Services (GRS) launches new website

With so many changes going on in the world: new regulations, new technology and new leaders to name just a few, we thought we would 'ring the changes' too by launching a 'new look' website. More »
24 April 2017

In Vitro Testing for Subcutaneous Formulations Under Biorelevant Conditions

Through CRACK IT Solutions, Sirius Analytical are seeking partners to help validate and further develop their Scissor platform for in vitro formulation performance analysis More »
21 April 2017

Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy

Pilot study demonstrates FAIMS technology is able to detect patients inadequately prepped prior to colonoscopy with 100% sensitivity More »
19 April 2017

CRT Pioneer Fund, Cancer Research UK and NCI Collaborate to Boost Research Against the ‘Undruggable’ RAS

Cancer Research UK and the Cancer Research Technology Pioneer Fund (CPF) have committed £2.5 million in collaboration with the National Cancer Institute (NCI) in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years. More »
19 April 2017

The RSA Group appoints Shawn O’Connor as Partner in New Jersey

The RSA Group, a leading Life Sciences executive search firm, is pleased to announce the appointment of Shawn O’Connor as Partner. More »
19 April 2017

<< Previous   Page 1 of 25   Next >>